Import Carvedilol — Buy in Bulk from Supplier in China

Carvedilol is a non-selective beta-blocker and alpha-1 blocker used in the management of heart failure and hypertension, supplied here as a pure active pharmaceutical ingredient. The compound is chemically designated as 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol, with a molecular formula of C24H26N2O4 and a molecular weight of 406.5 g/mol. This listing originates from Shandong Kangnuo Bioengineering Co., Ltd in Dongzhao Development Zone, Huanghelu, Dongying, Shandong, China, and is positioned for bulk pharmaceutical export.

The API is typically provided in crystalline powder form, white to off-white in colour, with a melting point range standard for the compound at approximately 114-116°C. Carvedilol is sparingly soluble in water but freely soluble in organic solvents such as methanol and dimethylformamide, a typical profile for lipophilic beta-blockers. Industry standards for pharmaceutical-grade carvedilol include a purity assay of not less than 99.0% by HPLC, with related substances controlled below 0.5% as per USP, EP, or BP monographs.

Hospitals, clinics, and generic drug manufacturers source carvedilol API for formulation into tablets, commonly in 6.25 mg, 12.5 mg, and 25 mg strengths. Bulk importers should confirm the supplier’s compliance with cGMP and ICH guidelines, as well as the availability of a Certificate of Analysis for each batch. Logistics for pharmaceutical APIs often require temperature-controlled shipping at 15-25°C, with packaging in double polyethylene bags sealed in fibre drums to maintain stability during transit.

Shandong Kangnuo Bioengineering Co., Ltd is based in Dongzhao Development Zone, Huanghelu, Dongying, Shandong Province, China, where it operates as an importer-tier pharmaceutical supplier. The company’s profile does not list a response rate or average response time, indicating a need for direct contact to confirm trade details. No additional verification signals, certifications, or client references are provided in the available data.

The supplier specializes in the export of active pharmaceutical ingredients, including carvedilol, and positions itself for bulk B2B transactions. While the listing does not disclose production capacity, manufacturing standards, or regulatory approvals, the focus remains on the product’s pharmaceutical grade and export readiness. Buyers are advised to request documentation such as cGMP compliance, ICH adherence, and batch-specific Certificates of Analysis to assess suitability.